Comprehensive Market Report: Global Gastrointestinal (GI) Stents Market
Executive Summary
The global Gastrointestinal (GI) Stents market is a critical segment within the interventional gastroenterology and surgical device landscape. GI stents are life-enhancing and often life-saving devices used to maintain patency in obstructed lumens of the digestive tract, offering palliative relief and bridging to definitive surgery. The market, valued at an estimated USD XX billion in 2025, is projected to expand to approximately USD YY billion by 2036, advancing at a steady Compound Annual Growth Rate (CAGR) of Z% from 2026 to 2036. This growth is driven by the rising global incidence of gastrointestinal cancers, an aging population, and the increasing preference for minimally invasive endoscopic procedures over open surgery. This report provides a strategic analysis of product innovation, application areas, and competitive dynamics.
1. Segments Analysis
By Product Type & Location:
-
Esophageal Stents: Used for malignant obstructions and strictures. Dominated by self-expanding metal stents (SEMS), with growing use of fully covered stents to reduce tissue ingrowth and facilitate removability.
-
Biliary Stents (Largest Segment): Critical for managing malignant biliary obstruction (e.g., pancreatic cancer) and benign conditions (e.g., strictures, post-surgical leaks).
-
Plastic Stents (PCS): Low-cost, used for short-term drainage but prone to occlusion.
-
Uncovered/Metal Biliary Stents (UMS): Permanent, high patency, but not removable.
-
Covered Self-Expanding Metal Stents (CSEMS): Growing segment; balance of patency, removability, and reduced tissue ingrowth.
-
-
Duodenal Stents: For gastric outlet obstruction (GOO), primarily due to pancreatic or gastric cancers. SEMS are standard.
-
Colonic Stents: Used as a "bridge to surgery" in acute malignant colonic obstruction to avoid emergency colostomy and allow for single-stage resection, or for palliative care.
-
Pancreatic Stents: Used for drainage of pancreatic ducts in chronic pancreatitis, post-operative leaks, or to prevent post-ERCP pancreatitis.
By Material & Design:
-
Metal Stents (SEMS): The dominant material, typically made of Nitinol (nickel-titanium alloy) for its superelasticity and shape memory. Includes uncovered, partially covered, and fully covered variants.
-
Plastic Stents (PCS): Polyethylene or Teflon-based, primarily for short-term biliary and pancreatic applications.
-
Biodegradable Stents (Emerging Segment): Designed to provide temporary support and then dissolve, eliminating the need for a second removal procedure. A high-potential innovation area.
By Application:
-
Malignant Obstructions (Primary Driver): Palliative relief for inoperable cancers (esophageal, pancreatic, colorectal, gastric) causing luminal or biliary blockage.
-
Benign Strictures: Treatment of refractory peptic, anastomotic, or corrosive strictures. Requires removable or biodegradable stents.
-
Post-Surgical Complications: Management of leaks, fistulas, and anastomotic strictures following GI surgery.
2. Key Players
The market is consolidated among a few global medical device leaders, with strong competition in innovation and emerging markets.
Leading Companies:
-
Boston Scientific Corporation (Leader in biliary and esophageal stents, WallFlex®, Wallstent®)
-
Cook Medical LLC (Comprehensive portfolio, Zilver® biliary stents)
-
Becton, Dickinson and Company (BD) (Via acquisition of C.R. Bard)
-
Olympus Corporation (Endoscopy leader with stent portfolio)
-
Taewoong Medical Co., Ltd. (South Korean innovator, Niti-S® stents)
-
ELLA-CS, s.r.o. (Specialist in biodegradable stents, ELLA® BD)
-
CONMED Corporation (Biliary and enteral stents)
-
W. L. Gore & Associates, Inc. (VIABIL® biliary stents)
-
Merit Medical Systems, Inc. (Via its Endotek division)
-
Medtronic plc (Through its hepatopancreatobiliary portfolio)
-
Hobbs Medical, Inc. (Specialized enteral stents)
-
Micro-Tech (Nanjing) Co., Ltd. (Leading Chinese manufacturer)
-
M.I. Tech Co., Ltd. (South Korean innovator)
3. Regional Analysis
-
North America: The largest market, driven by high healthcare expenditure, advanced endoscopic procedural volumes, favorable reimbursement, and a high incidence of GI cancers. The U.S. is the center of innovation and premium product adoption.
-
Europe: A mature market with strong adoption of minimally invasive techniques. Growth is steady, supported by an aging population and established interventional gastroenterology practices. Germany, France, and the UK are key markets.
-
Asia-Pacific: The fastest-growing regional market. Driven by a large and aging population, rising cancer incidence, improving healthcare infrastructure, and growing expertise in advanced endoscopy. Japan, China, and South Korea are major contributors.
-
Latin America, Middle East & Africa: Emerging markets with growing access to endoscopic procedures. Growth is concentrated in major urban hospitals and private healthcare sectors in countries like Brazil, Mexico, Saudi Arabia, and South Africa.
4. Porter’s Five Forces Analysis
-
Competitive Rivalry (High): The market is an oligopoly with 3-4 major players holding significant share. Competition is intense on product performance (patency, deliverability, removability), physician training, and price, especially in the commodity-like plastic stent segment.
-
Bargaining Power of Suppliers (Low): Raw materials like Nitinol, polymers, and radiopaque markers are available from multiple suppliers. Large device manufacturers have significant purchasing power.
-
Bargaining Power of Buyers (High): Buyers are large hospital groups and government procurement agencies. They negotiate aggressively on price, especially for high-volume commodity products (plastic stents). For innovative stents, clinical data and physician preference moderate buyer power.
-
Threat of New Entrants (Moderate): Barriers are high due to stringent regulatory requirements (FDA 510(k)/PMA, CE Mark), need for clinical data, and established physician relationships. However, specialized companies from Asia (e.g., Taewoong, Micro-Tech) have successfully entered with cost-competitive and innovative products.
-
Threat of Substitutes (Low to Moderate): Surgical bypass or resection is the main alternative but is more invasive with higher morbidity. Alternative endoscopic therapies (e.g., balloon dilation, ablation) are often temporary or adjunctive, not direct substitutes for stent placement in malignant obstruction.
5. SWOT Analysis
-
Strengths: Critical, minimally invasive solution for life-threatening obstructions; well-established clinical guidelines supporting use; strong brand loyalty among interventional gastroenterologists and surgeons; recurring procedural demand.
-
Weaknesses: Complications like stent migration, occlusion, and tissue hyperplasia; price erosion in mature stent categories; procedural complexity requiring highly trained specialists.
-
Opportunities: Development of next-generation stents with drug-elution (anti-cancer, anti-hyperplasia), biodegradable materials, and anti-migration designs; expansion in emerging markets as endoscopic capabilities grow.
-
Threats: Intense pricing pressure from healthcare cost containment; potential for alternative cancer therapies (e.g., improved systemic chemo/immunotherapy) to reduce incidence of obstructive complications; product recalls due to material or design flaws.
6. Trend Analysis, Drivers & Challenges
Key Trends:
-
Shift Towards Fully Covered & Lumen-Apposing Stents: For better removability, management of leaks/fistulas, and reduced tissue ingrowth. Lumen-apposing metal stents (LAMS) represent a major innovation for transmural drainage (e.g., EUS-guided gallbladder drainage).
-
Drug-Eluting Stents (DES): Early-stage development of stents coated with chemotherapeutic (e.g., paclitaxel) or anti-hyperplastic agents to prolong patency and provide local tumor control.
-
Biodegradable Stent Technology: A paradigm shift aiming to provide temporary support without the need for removal, particularly attractive for benign indications.
-
Customization & 3D Printing: Exploration of patient-specific stents for complex anatomies.
Primary Drivers:
-
Rising Global Burden of GI Cancers: Increasing incidence of esophageal, gastric, pancreatic, and colorectal cancers, leading to higher demand for palliative stenting.
-
Aging Population: Older adults are at higher risk for both malignancies and benign strictures requiring intervention.
-
Growth of Therapeutic Endoscopy: Expansion of Endoscopic Ultrasound (EUS) and advanced endoscopic skills, enabling more complex stent placements (e.g., EUS-guided biliary/duodenal drainage).
-
Preference for Minimally Invasive Procedures: Over traditional surgery, reducing hospital stays, complications, and costs.
Critical Challenges:
-
Stent-Related Complications: Occlusion (from tumor/tissue ingrowth or sludge), migration, and perforation remain clinical challenges, driving re-intervention rates.
-
Reimbursement and Cost Pressure: Particularly for premium-priced innovative stents, requiring robust clinical data to justify cost.
-
Regulatory Hurdles for Novel Designs: Bringing truly innovative materials (biodegradable, drug-eluting) to market requires extensive and costly clinical trials.
7. Value Chain Analysis
-
R&D & Design: Focus on material science (Nitinol alloys, biodegradable polymers), stent architecture, and delivery system ergonomics.
-
Manufacturing: Precision engineering of stents (laser cutting, electro-polishing) and assembly of delivery catheters. Often requires clean-room facilities.
-
Regulatory Affairs & Clinical Trials: Securing approvals (FDA, CE, NMPA) with clinical data demonstrating safety and efficacy.
-
Marketing, Sales & Physician Training: Direct sales to hospitals, with heavy emphasis on hands-on physician training and proctoring for complex procedures. Key Opinion Leader (KOL) engagement is crucial.
-
Distribution & Logistics: Efficient supply chain to ensure product availability in hospitals and endoscopy suites.
-
Procedure & Implantation: Performed by interventional gastroenterologists or surgeons in hospital settings.
-
Post-Market Surveillance & Support: Monitoring long-term performance and managing complications.
Maximum value is captured by companies that control proprietary material technology, innovative stent designs, and have a strong direct sales and training relationship with high-volume endoscopists.
8. Quick Recommendations for Stakeholders
-
For Established Market Leaders (Boston Scientific, Cook Medical): Defend core markets (biliary, esophageal) with continuous incremental improvements in deliverability and patency. Aggressively invest in and commercialize next-generation platforms like LAMS and drug-eluting stents to create new market segments. Expand educational programs in high-growth APAC regions to build brand loyalty among new endoscopists.
-
For Innovative Challengers (Taewoong, ELLA-CS): Leverage cost-competitiveness and specialized designs (e.g., biodegradable stents) to gain share in price-sensitive markets and specific clinical niches. Form strategic partnerships or seek distribution deals with larger global players or regional distributors to expand geographic reach.
-
For Hospitals & Healthcare Providers: Standardize stent formularies based on clinical evidence and total cost of care (including re-intervention rates), not just upfront price. Invest in advanced endoscopy training for staff to optimize procedural outcomes and minimize complications with complex stents.
-
For Investors: Focus on companies with differentiated IP in high-growth segments (biodegradable, drug-eluting, LAMS). Monitor clinical trial outcomes for novel stent technologies as key value inflection points. Consider the defensive nature of the market, as demand is tied to essential palliative care, providing resilience during economic cycles.
-
For New Entrants: Given high barriers, consider focusing on unmet niche applications (e.g., pediatric GI stenting, specialized fistula management) or disruptive delivery system technologies. A partnership or acquisition by a larger player is a likely exit strategy.
Report Basis: History Years: 2020-2024; Base Year: 2025; Forecast Period: 2026-2036.
Note: All market values (XX, YY) and CAGR (Z%) are illustrative placeholders. This analysis reflects structural market trends. Customized data, including application-specific forecasts, detailed competitive product matrix analysis, and pricing trend analysis, is available per client specifications.
Table of Contents
Global Gastrointestinal (GI) Stents Sales Market Report 2018
1 Gastrointestinal (GI) Stents Market Overview
1.1 Product Overview and Scope of Gastrointestinal (GI) Stents
1.2 Classification of Gastrointestinal (GI) Stents by Product Category
1.2.1 Global Gastrointestinal (GI) Stents Market Size (Sales) Comparison by Type
1.2.2 Global Gastrointestinal (GI) Stents Market Size (Sales) Market Share by Type (Product Category) in
1.2.3 Biliary Stents
1.2.4 Duodenal Stents
1.2.5 Colonic Stents
1.2.6 Pancreatic Stents
1.2.7 Esophageal Stents
1.3 Global Gastrointestinal (GI) Stents Market by Application/End Users
1.3.1 Global Gastrointestinal (GI) Stents Sales (Volume) and Market Share Comparison by Application
1.3.1 Biliary Disease
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.4 Global Gastrointestinal (GI) Stents Market by Region
1.4.1 Global Gastrointestinal (GI) Stents Market Size (Value) Comparison by Region
1.4.2 United States Gastrointestinal (GI) Stents Status and Prospect
1.4.3 Europe Gastrointestinal (GI) Stents Status and Prospect
1.4.4 China Gastrointestinal (GI) Stents Status and Prospect
1.4.5 Japan Gastrointestinal (GI) Stents Status and Prospect
1.4.6 Southeast Asia Gastrointestinal (GI) Stents Status and Prospect
1.4.7 India Gastrointestinal (GI) Stents Status and Prospect
1.5 Global Market Size (Value and Volume) of Gastrointestinal (GI) Stents
1.5.1 Global Gastrointestinal (GI) Stents Sales and Growth Rate
1.5.2 Global Gastrointestinal (GI) Stents Revenue and Growth Rate
2 Global Gastrointestinal (GI) Stents Competition by Players/Suppliers, Type and Application
2.1 Global Gastrointestinal (GI) Stents Market Competition by Players/Suppliers
2.1.1 Global Gastrointestinal (GI) Stents Sales and Market Share of Key Players/Suppliers ()
2.1.2 Global Gastrointestinal (GI) Stents Revenue and Share by Players/Suppliers ()
2.2 Global Gastrointestinal (GI) Stents (Volume and Value) by Type
2.2.1 Global Gastrointestinal (GI) Stents Sales and Market Share by Type ()
2.2.2 Global Gastrointestinal (GI) Stents Revenue and Market Share by Type ()
2.3 Global Gastrointestinal (GI) Stents (Volume and Value) by Region
2.3.1 Global Gastrointestinal (GI) Stents Sales and Market Share by Region ()
2.3.2 Global Gastrointestinal (GI) Stents Revenue and Market Share by Region ()
2.4 Global Gastrointestinal (GI) Stents (Volume) by Application
3 United States Gastrointestinal (GI) Stents (Volume, Value and Sales Price)
3.1 United States Gastrointestinal (GI) Stents Sales and Value ()
3.1.1 United States Gastrointestinal (GI) Stents Sales and Growth Rate ()
3.1.2 United States Gastrointestinal (GI) Stents Revenue and Growth Rate ()
3.1.3 United States Gastrointestinal (GI) Stents Sales Price Trend ()
3.2 United States Gastrointestinal (GI) Stents Sales Volume and Market Share by Players ()
3.3 United States Gastrointestinal (GI) Stents Sales Volume and Market Share by Type ()
3.4 United States Gastrointestinal (GI) Stents Sales Volume and Market Share by Application ()
4 Europe Gastrointestinal (GI) Stents (Volume, Value and Sales Price)
4.1 Europe Gastrointestinal (GI) Stents Sales and Value ()
4.1.1 Europe Gastrointestinal (GI) Stents Sales and Growth Rate ()
4.1.2 Europe Gastrointestinal (GI) Stents Revenue and Growth Rate ()
4.1.3 Europe Gastrointestinal (GI) Stents Sales Price Trend ()
4.2 Europe Gastrointestinal (GI) Stents Sales Volume and Market Share by Players ()
4.3 Europe Gastrointestinal (GI) Stents Sales Volume and Market Share by Type ()
4.4 Europe Gastrointestinal (GI) Stents Sales Volume and Market Share by Application ()
5 China Gastrointestinal (GI) Stents (Volume, Value and Sales Price)
5.1 China Gastrointestinal (GI) Stents Sales and Value ()
5.1.1 China Gastrointestinal (GI) Stents Sales and Growth Rate ()
5.1.2 China Gastrointestinal (GI) Stents Revenue and Growth Rate ()
5.1.3 China Gastrointestinal (GI) Stents Sales Price Trend ()
5.2 China Gastrointestinal (GI) Stents Sales Volume and Market Share by Players ()
5.3 China Gastrointestinal (GI) Stents Sales Volume and Market Share by Type ()
5.4 China Gastrointestinal (GI) Stents Sales Volume and Market Share by Application ()
6 Japan Gastrointestinal (GI) Stents (Volume, Value and Sales Price)
6.1 Japan Gastrointestinal (GI) Stents Sales and Value ()
6.1.1 Japan Gastrointestinal (GI) Stents Sales and Growth Rate ()
6.1.2 Japan Gastrointestinal (GI) Stents Revenue and Growth Rate ()
6.1.3 Japan Gastrointestinal (GI) Stents Sales Price Trend ()
6.2 Japan Gastrointestinal (GI) Stents Sales Volume and Market Share by Players ()
6.3 Japan Gastrointestinal (GI) Stents Sales Volume and Market Share by Type ()
6.4 Japan Gastrointestinal (GI) Stents Sales Volume and Market Share by Application ()
7 Southeast Asia Gastrointestinal (GI) Stents (Volume, Value and Sales Price)
7.1 Southeast Asia Gastrointestinal (GI) Stents Sales and Value ()
7.1.1 Southeast Asia Gastrointestinal (GI) Stents Sales and Growth Rate ()
7.1.2 Southeast Asia Gastrointestinal (GI) Stents Revenue and Growth Rate ()
7.1.3 Southeast Asia Gastrointestinal (GI) Stents Sales Price Trend ()
7.2 Southeast Asia Gastrointestinal (GI) Stents Sales Volume and Market Share by Players ()
7.3 Southeast Asia Gastrointestinal (GI) Stents Sales Volume and Market Share by Type ()
7.4 Southeast Asia Gastrointestinal (GI) Stents Sales Volume and Market Share by Application ()
8 India Gastrointestinal (GI) Stents (Volume, Value and Sales Price)
8.1 India Gastrointestinal (GI) Stents Sales and Value ()
8.1.1 India Gastrointestinal (GI) Stents Sales and Growth Rate ()
8.1.2 India Gastrointestinal (GI) Stents Revenue and Growth Rate ()
8.1.3 India Gastrointestinal (GI) Stents Sales Price Trend ()
8.2 India Gastrointestinal (GI) Stents Sales Volume and Market Share by Players ()
8.3 India Gastrointestinal (GI) Stents Sales Volume and Market Share by Type ()
8.4 India Gastrointestinal (GI) Stents Sales Volume and Market Share by Application ()
9 Global Gastrointestinal (GI) Stents Players/Suppliers Profiles and Sales Data
9.1 Boston Scientific
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Gastrointestinal (GI) Stents Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Boston Scientific Gastrointestinal (GI) Stents Sales, Revenue, Price and Gross Margin ()
9.1.4 Main Business/Business Overview
9.2 Cook Medical
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Gastrointestinal (GI) Stents Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Cook Medical Gastrointestinal (GI) Stents Sales, Revenue, Price and Gross Margin ()
9.2.4 Main Business/Business Overview
9.3 ELLA-CS
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Gastrointestinal (GI) Stents Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 ELLA-CS Gastrointestinal (GI) Stents Sales, Revenue, Price and Gross Margin ()
9.3.4 Main Business/Business Overview
9.4 ConMed
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Gastrointestinal (GI) Stents Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 ConMed Gastrointestinal (GI) Stents Sales, Revenue, Price and Gross Margin ()
9.4.4 Main Business/Business Overview
9.5 Gore Medical
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Gastrointestinal (GI) Stents Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Gore Medical Gastrointestinal (GI) Stents Sales, Revenue, Price and Gross Margin ()
9.5.4 Main Business/Business Overview
9.6 Taewoong Medical
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Gastrointestinal (GI) Stents Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Taewoong Medical Gastrointestinal (GI) Stents Sales, Revenue, Price and Gross Margin ()
9.6.4 Main Business/Business Overview
9.7 Hobbs Medical
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Gastrointestinal (GI) Stents Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Hobbs Medical Gastrointestinal (GI) Stents Sales, Revenue, Price and Gross Margin ()
9.7.4 Main Business/Business Overview
9.8 C.R. Bard
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Gastrointestinal (GI) Stents Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 C.R. Bard Gastrointestinal (GI) Stents Sales, Revenue, Price and Gross Margin ()
9.8.4 Main Business/Business Overview
9.9 Merit Endotek
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Gastrointestinal (GI) Stents Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Merit Endotek Gastrointestinal (GI) Stents Sales, Revenue, Price and Gross Margin ()
9.9.4 Main Business/Business Overview
9.10 Olympus America
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Gastrointestinal (GI) Stents Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Olympus America Gastrointestinal (GI) Stents Sales, Revenue, Price and Gross Margin ()
9.10.4 Main Business/Business Overview
10 Gastrointestinal (GI) Stents Maufacturing Cost Analysis
10.1 Gastrointestinal (GI) Stents Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Gastrointestinal (GI) Stents
10.3 Manufacturing Process Analysis of Gastrointestinal (GI) Stents
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Gastrointestinal (GI) Stents Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Gastrointestinal (GI) Stents Major Manufacturers in
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Gastrointestinal (GI) Stents Market Forecast (2018-2025)
14.1 Global Gastrointestinal (GI) Stents Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Gastrointestinal (GI) Stents Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Gastrointestinal (GI) Stents Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Gastrointestinal (GI) Stents Price and Trend Forecast (2018-2025)
14.2 Global Gastrointestinal (GI) Stents Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Gastrointestinal (GI) Stents Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Gastrointestinal (GI) Stents Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Gastrointestinal (GI) Stents Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Gastrointestinal (GI) Stents Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Gastrointestinal (GI) Stents Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Gastrointestinal (GI) Stents Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Gastrointestinal (GI) Stents Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Gastrointestinal (GI) Stents Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Gastrointestinal (GI) Stents Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Gastrointestinal (GI) Stents Sales Forecast by Type (2018-2025)
14.3.2 Global Gastrointestinal (GI) Stents Revenue Forecast by Type (2018-2025)
14.3.3 Global Gastrointestinal (GI) Stents Price Forecast by Type (2018-2025)
14.4 Global Gastrointestinal (GI) Stents Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Gastrointestinal (GI) Stents
Figure Global Gastrointestinal (GI) Stents Sales Volume Comparison (K Units) by Type
Figure Global Gastrointestinal (GI) Stents Sales Volume Market Share by Type (Product Category) in
Figure Biliary Stents Product Picture
Figure Duodenal Stents Product Picture
Figure Colonic Stents Product Picture
Figure Pancreatic Stents Product Picture
Figure Esophageal Stents Product Picture
Figure Global Gastrointestinal (GI) Stents Sales Comparison (K Units) by Application
Figure Global Sales Market Share of Gastrointestinal (GI) Stents by Application in
Figure Biliary Disease Examples
Table Key Downstream Customer in Biliary Disease
Figure Colorectal Cancer Examples
Table Key Downstream Customer in Colorectal Cancer
Figure Stomach Cancer Examples
Table Key Downstream Customer in Stomach Cancer
Figure Global Gastrointestinal (GI) Stents Market Size (Million USD) by Regions
Figure United States Gastrointestinal (GI) Stents Revenue (Million USD) and Growth Rate
Figure Europe Gastrointestinal (GI) Stents Revenue (Million USD) and Growth Rate
Figure China Gastrointestinal (GI) Stents Revenue (Million USD) and Growth Rate
Figure Japan Gastrointestinal (GI) Stents Revenue (Million USD) and Growth Rate
Figure Southeast Asia Gastrointestinal (GI) Stents Revenue (Million USD) and Growth Rate
Figure India Gastrointestinal (GI) Stents Revenue (Million USD) and Growth Rate
Figure Global Gastrointestinal (GI) Stents Sales Volume (K Units) and Growth Rate
Figure Global Gastrointestinal (GI) Stents Revenue (Million USD) and Growth Rate
Figure Global Market Major Players Gastrointestinal (GI) Stents Sales Volume (K Units) ()
Table Global Gastrointestinal (GI) Stents Sales (K Units) of Key Players/Suppliers ()
Table Global Gastrointestinal (GI) Stents Sales Share by Players/Suppliers ()
Figure Gastrointestinal (GI) Stents Sales Share by Players/Suppliers
Figure Gastrointestinal (GI) Stents Sales Share by Players/Suppliers
Figure Global Gastrointestinal (GI) Stents Revenue (Million USD) by Players/Suppliers ()
Table Global Gastrointestinal (GI) Stents Revenue (Million USD) by Players/Suppliers ()
Table Global Gastrointestinal (GI) Stents Revenue Share by Players/Suppliers ()
Table Global Gastrointestinal (GI) Stents Revenue Share by Players
Table Global Gastrointestinal (GI) Stents Revenue Share by Players
Table Global Gastrointestinal (GI) Stents Sales (K Units) and Market Share by Type ()
Table Global Gastrointestinal (GI) Stents Sales Share (K Units) by Type ()
Figure Sales Market Share of Gastrointestinal (GI) Stents by Type ()
Figure Global Gastrointestinal (GI) Stents Sales Growth Rate by Type ()
Table Global Gastrointestinal (GI) Stents Revenue (Million USD) and Market Share by Type ()
Table Global Gastrointestinal (GI) Stents Revenue Share by Type ()
Figure Revenue Market Share of Gastrointestinal (GI) Stents by Type ()
Figure Global Gastrointestinal (GI) Stents Revenue Growth Rate by Type ()
Table Global Gastrointestinal (GI) Stents Sales Volume (K Units) and Market Share by Region ()
Table Global Gastrointestinal (GI) Stents Sales Share by Region ()
Figure Sales Market Share of Gastrointestinal (GI) Stents by Region ()
Figure Global Gastrointestinal (GI) Stents Sales Growth Rate by Region in
Table Global Gastrointestinal (GI) Stents Revenue (Million USD) and Market Share by Region ()
Table Global Gastrointestinal (GI) Stents Revenue Share (%) by Region ()
Figure Revenue Market Share of Gastrointestinal (GI) Stents by Region ()
Figure Global Gastrointestinal (GI) Stents Revenue Growth Rate by Region in
Table Global Gastrointestinal (GI) Stents Revenue (Million USD) and Market Share by Region ()
Table Global Gastrointestinal (GI) Stents Revenue Share (%) by Region ()
Figure Revenue Market Share of Gastrointestinal (GI) Stents by Region ()
Figure Global Gastrointestinal (GI) Stents Revenue Market Share by Region in
Table Global Gastrointestinal (GI) Stents Sales Volume (K Units) and Market Share by Application ()
Table Global Gastrointestinal (GI) Stents Sales Share (%) by Application ()
Figure Sales Market Share of Gastrointestinal (GI) Stents by Application ()
Figure Global Gastrointestinal (GI) Stents Sales Market Share by Application ()
Figure United States Gastrointestinal (GI) Stents Sales (K Units) and Growth Rate ()
Figure United States Gastrointestinal (GI) Stents Revenue (Million USD) and Growth Rate ()
Figure United States Gastrointestinal (GI) Stents Sales Price (USD/Unit) Trend ()
Table United States Gastrointestinal (GI) Stents Sales Volume (K Units) by Players ()
Table United States Gastrointestinal (GI) Stents Sales Volume Market Share by Players ()
Figure United States Gastrointestinal (GI) Stents Sales Volume Market Share by Players in
Table United States Gastrointestinal (GI) Stents Sales Volume (K Units) by Type ()
Table United States Gastrointestinal (GI) Stents Sales Volume Market Share by Type ()
Figure United States Gastrointestinal (GI) Stents Sales Volume Market Share by Type in
Table United States Gastrointestinal (GI) Stents Sales Volume (K Units) by Application ()
Table United States Gastrointestinal (GI) Stents Sales Volume Market Share by Application ()
Figure United States Gastrointestinal (GI) Stents Sales Volume Market Share by Application in
Figure Europe Gastrointestinal (GI) Stents Sales (K Units) and Growth Rate ()
Figure Europe Gastrointestinal (GI) Stents Revenue (Million USD) and Growth Rate ()
Figure Europe Gastrointestinal (GI) Stents Sales Price (USD/Unit) Trend ()
Table Europe Gastrointestinal (GI) Stents Sales Volume (K Units) by Players ()
Table Europe Gastrointestinal (GI) Stents Sales Volume Market Share by Players ()
Figure Europe Gastrointestinal (GI) Stents Sales Volume Market Share by Players in
Table Europe Gastrointestinal (GI) Stents Sales Volume (K Units) by Type ()
Table Europe Gastrointestinal (GI) Stents Sales Volume Market Share by Type ()
Figure Europe Gastrointestinal (GI) Stents Sales Volume Market Share by Type in
Table Europe Gastrointestinal (GI) Stents Sales Volume (K Units) by Application ()
Table Europe Gastrointestinal (GI) Stents Sales Volume Market Share by Application ()
Figure Europe Gastrointestinal (GI) Stents Sales Volume Market Share by Application in
Figure China Gastrointestinal (GI) Stents Sales (K Units) and Growth Rate ()
Figure China Gastrointestinal (GI) Stents Revenue (Million USD) and Growth Rate ()
Figure China Gastrointestinal (GI) Stents Sales Price (USD/Unit) Trend ()
Table China Gastrointestinal (GI) Stents Sales Volume (K Units) by Players ()
Table China Gastrointestinal (GI) Stents Sales Volume Market Share by Players ()
Figure China Gastrointestinal (GI) Stents Sales Volume Market Share by Players in
Table China Gastrointestinal (GI) Stents Sales Volume (K Units) by Type ()
Table China Gastrointestinal (GI) Stents Sales Volume Market Share by Type ()
Figure China Gastrointestinal (GI) Stents Sales Volume Market Share by Type in
Table China Gastrointestinal (GI) Stents Sales Volume (K Units) by Application ()
Table China Gastrointestinal (GI) Stents Sales Volume Market Share by Application ()
Figure China Gastrointestinal (GI) Stents Sales Volume Market Share by Application in
Figure Japan Gastrointestinal (GI) Stents Sales (K Units) and Growth Rate ()
Figure Japan Gastrointestinal (GI) Stents Revenue (Million USD) and Growth Rate ()
Figure Japan Gastrointestinal (GI) Stents Sales Price (USD/Unit) Trend ()
Table Japan Gastrointestinal (GI) Stents Sales Volume (K Units) by Players ()
Table Japan Gastrointestinal (GI) Stents Sales Volume Market Share by Players ()
Figure Japan Gastrointestinal (GI) Stents Sales Volume Market Share by Players in
Table Japan Gastrointestinal (GI) Stents Sales Volume (K Units) by Type ()
Table Japan Gastrointestinal (GI) Stents Sales Volume Market Share by Type ()
Figure Japan Gastrointestinal (GI) Stents Sales Volume Market Share by Type in
Table Japan Gastrointestinal (GI) Stents Sales Volume (K Units) by Application ()
Table Japan Gastrointestinal (GI) Stents Sales Volume Market Share by Application ()
Figure Japan Gastrointestinal (GI) Stents Sales Volume Market Share by Application in
Figure Southeast Asia Gastrointestinal (GI) Stents Sales (K Units) and Growth Rate ()
Figure Southeast Asia Gastrointestinal (GI) Stents Revenue (Million USD) and Growth Rate ()
Figure Southeast Asia Gastrointestinal (GI) Stents Sales Price (USD/Unit) Trend ()
Table Southeast Asia Gastrointestinal (GI) Stents Sales Volume (K Units) by Players ()
Table Southeast Asia Gastrointestinal (GI) Stents Sales Volume Market Share by Players ()
Figure Southeast Asia Gastrointestinal (GI) Stents Sales Volume Market Share by Players in
Table Southeast Asia Gastrointestinal (GI) Stents Sales Volume (K Units) by Type ()
Table Southeast Asia Gastrointestinal (GI) Stents Sales Volume Market Share by Type ()
Figure Southeast Asia Gastrointestinal (GI) Stents Sales Volume Market Share by Type in
Table Southeast Asia Gastrointestinal (GI) Stents Sales Volume (K Units) by Application ()
Table Southeast Asia Gastrointestinal (GI) Stents Sales Volume Market Share by Application ()
Figure Southeast Asia Gastrointestinal (GI) Stents Sales Volume Market Share by Application in
Figure India Gastrointestinal (GI) Stents Sales (K Units) and Growth Rate ()
Figure India Gastrointestinal (GI) Stents Revenue (Million USD) and Growth Rate ()
Figure India Gastrointestinal (GI) Stents Sales Price (USD/Unit) Trend ()
Table India Gastrointestinal (GI) Stents Sales Volume (K Units) by Players ()
Table India Gastrointestinal (GI) Stents Sales Volume Market Share by Players ()
Figure India Gastrointestinal (GI) Stents Sales Volume Market Share by Players in
Table India Gastrointestinal (GI) Stents Sales Volume (K Units) by Type ()
Table India Gastrointestinal (GI) Stents Sales Volume Market Share by Type ()
Figure India Gastrointestinal (GI) Stents Sales Volume Market Share by Type in
Table India Gastrointestinal (GI) Stents Sales Volume (K Units) by Application ()
Table India Gastrointestinal (GI) Stents Sales Volume Market Share by Application ()
Figure India Gastrointestinal (GI) Stents Sales Volume Market Share by Application in
Table Boston Scientific Basic Information List
Table Boston Scientific Gastrointestinal (GI) Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Boston Scientific Gastrointestinal (GI) Stents Sales Growth Rate ()
Figure Boston Scientific Gastrointestinal (GI) Stents Sales Global Market Share ()
Figure Boston Scientific Gastrointestinal (GI) Stents Revenue Global Market Share ()
Table Cook Medical Basic Information List
Table Cook Medical Gastrointestinal (GI) Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Cook Medical Gastrointestinal (GI) Stents Sales Growth Rate ()
Figure Cook Medical Gastrointestinal (GI) Stents Sales Global Market Share ()
Figure Cook Medical Gastrointestinal (GI) Stents Revenue Global Market Share ()
Table ELLA-CS Basic Information List
Table ELLA-CS Gastrointestinal (GI) Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure ELLA-CS Gastrointestinal (GI) Stents Sales Growth Rate ()
Figure ELLA-CS Gastrointestinal (GI) Stents Sales Global Market Share (
Figure ELLA-CS Gastrointestinal (GI) Stents Revenue Global Market Share ()
Table ConMed Basic Information List
Table ConMed Gastrointestinal (GI) Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure ConMed Gastrointestinal (GI) Stents Sales Growth Rate ()
Figure ConMed Gastrointestinal (GI) Stents Sales Global Market Share ()
Figure ConMed Gastrointestinal (GI) Stents Revenue Global Market Share ()
Table Gore Medical Basic Information List
Table Gore Medical Gastrointestinal (GI) Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Gore Medical Gastrointestinal (GI) Stents Sales Growth Rate ()
Figure Gore Medical Gastrointestinal (GI) Stents Sales Global Market Share ()
Figure Gore Medical Gastrointestinal (GI) Stents Revenue Global Market Share ()
Table Taewoong Medical Basic Information List
Table Taewoong Medical Gastrointestinal (GI) Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Taewoong Medical Gastrointestinal (GI) Stents Sales Growth Rate ()
Figure Taewoong Medical Gastrointestinal (GI) Stents Sales Global Market Share (
Figure Taewoong Medical Gastrointestinal (GI) Stents Revenue Global Market Share ()
Table Hobbs Medical Basic Information List
Table Hobbs Medical Gastrointestinal (GI) Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Hobbs Medical Gastrointestinal (GI) Stents Sales Growth Rate ()
Figure Hobbs Medical Gastrointestinal (GI) Stents Sales Global Market Share ()
Figure Hobbs Medical Gastrointestinal (GI) Stents Revenue Global Market Share ()
Table C.R. Bard Basic Information List
Table C.R. Bard Gastrointestinal (GI) Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure C.R. Bard Gastrointestinal (GI) Stents Sales Growth Rate ()
Figure C.R. Bard Gastrointestinal (GI) Stents Sales Global Market Share (
Figure C.R. Bard Gastrointestinal (GI) Stents Revenue Global Market Share ()
Table Merit Endotek Basic Information List
Table Merit Endotek Gastrointestinal (GI) Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Merit Endotek Gastrointestinal (GI) Stents Sales Growth Rate ()
Figure Merit Endotek Gastrointestinal (GI) Stents Sales Global Market Share ()
Figure Merit Endotek Gastrointestinal (GI) Stents Revenue Global Market Share ()
Table Olympus America Basic Information List
Table Olympus America Gastrointestinal (GI) Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Olympus America Gastrointestinal (GI) Stents Sales Growth Rate ()
Figure Olympus America Gastrointestinal (GI) Stents Sales Global Market Share ()
Figure Olympus America Gastrointestinal (GI) Stents Revenue Global Market Share ()
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal (GI) Stents
Figure Manufacturing Process Analysis of Gastrointestinal (GI) Stents
Figure Gastrointestinal (GI) Stents Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal (GI) Stents Major Players in
Table Major Buyers of Gastrointestinal (GI) Stents
Table Distributors/Traders List
Figure Global Gastrointestinal (GI) Stents Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Gastrointestinal (GI) Stents Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Gastrointestinal (GI) Stents Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Gastrointestinal (GI) Stents Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Gastrointestinal (GI) Stents Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Gastrointestinal (GI) Stents Sales Volume Market Share Forecast by Regions in 2025
Table Global Gastrointestinal (GI) Stents Revenue (Mill
1. Segments Analysis
By Product Type & Location:
-
Esophageal Stents: Used for malignant obstructions and strictures. Dominated by self-expanding metal stents (SEMS), with growing use of fully covered stents to reduce tissue ingrowth and facilitate removability.
-
Biliary Stents (Largest Segment): Critical for managing malignant biliary obstruction (e.g., pancreatic cancer) and benign conditions (e.g., strictures, post-surgical leaks).
-
Plastic Stents (PCS): Low-cost, used for short-term drainage but prone to occlusion.
-
Uncovered/Metal Biliary Stents (UMS): Permanent, high patency, but not removable.
-
Covered Self-Expanding Metal Stents (CSEMS): Growing segment; balance of patency, removability, and reduced tissue ingrowth.
-
-
Duodenal Stents: For gastric outlet obstruction (GOO), primarily due to pancreatic or gastric cancers. SEMS are standard.
-
Colonic Stents: Used as a "bridge to surgery" in acute malignant colonic obstruction to avoid emergency colostomy and allow for single-stage resection, or for palliative care.
-
Pancreatic Stents: Used for drainage of pancreatic ducts in chronic pancreatitis, post-operative leaks, or to prevent post-ERCP pancreatitis.
By Material & Design:
-
Metal Stents (SEMS): The dominant material, typically made of Nitinol (nickel-titanium alloy) for its superelasticity and shape memory. Includes uncovered, partially covered, and fully covered variants.
-
Plastic Stents (PCS): Polyethylene or Teflon-based, primarily for short-term biliary and pancreatic applications.
-
Biodegradable Stents (Emerging Segment): Designed to provide temporary support and then dissolve, eliminating the need for a second removal procedure. A high-potential innovation area.
By Application:
-
Malignant Obstructions (Primary Driver): Palliative relief for inoperable cancers (esophageal, pancreatic, colorectal, gastric) causing luminal or biliary blockage.
-
Benign Strictures: Treatment of refractory peptic, anastomotic, or corrosive strictures. Requires removable or biodegradable stents.
-
Post-Surgical Complications: Management of leaks, fistulas, and anastomotic strictures following GI surgery.
2. Key Players
The market is consolidated among a few global medical device leaders, with strong competition in innovation and emerging markets.
Leading Companies:
-
Boston Scientific Corporation (Leader in biliary and esophageal stents, WallFlex®, Wallstent®)
-
Cook Medical LLC (Comprehensive portfolio, Zilver® biliary stents)
-
Becton, Dickinson and Company (BD) (Via acquisition of C.R. Bard)
-
Olympus Corporation (Endoscopy leader with stent portfolio)
-
Taewoong Medical Co., Ltd. (South Korean innovator, Niti-S® stents)
-
ELLA-CS, s.r.o. (Specialist in biodegradable stents, ELLA® BD)
-
CONMED Corporation (Biliary and enteral stents)
-
W. L. Gore & Associates, Inc. (VIABIL® biliary stents)
-
Merit Medical Systems, Inc. (Via its Endotek division)
-
Medtronic plc (Through its hepatopancreatobiliary portfolio)
-
Hobbs Medical, Inc. (Specialized enteral stents)
-
Micro-Tech (Nanjing) Co., Ltd. (Leading Chinese manufacturer)
-
M.I. Tech Co., Ltd. (South Korean innovator)
